Cancer Chemotherapy Abstracts

In addition to technical reports, the National Institutes of Health issue several other publications. One of these is the Journal of the National Cancer Institute which publishes not only a large part of the work done at the National Cancer Institute but also research in many other institutions in the U.S. and other countries. It is available from GPO at 20 a year for 12 issues. Another publication is the Psychopharmacology Service Center Bulletin which is distributed at irregular intervals by the Psychopharmocology Service Center, National Institute of Mental Health, Bethesda 14, Md. It is issued for information purposes to investigators interested in psychopharmacology. Two other publications of NIH are Cancer Chemotherapy Reports and Cancer Chemotherapy Abstracts which may be obtained from National Cancer Institute, Publication Office, Room 213 Robin Building, Bethesda 14, Md. 

Nicolini, M., Bandoli, G. (eds.) Fifth International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Abstracts. Padua Cleup 1987... 

Schiller JH, Harrington D, Sandler A, et al. A Randomized Phase III Trial of Four Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer (NSCLC) (abstract 2). 2000. Pro Am Soc Clin Oncol 19 1a. 

Shaw IC. 1987. MESNA and oxazaphosphorine chemotherapy [Abstract], In Anticancer Drugs Therapeutic Index Improvement by Toxicity Reduction, April 6-7, 1987, London, Westminster Hospital, Imperial Cancer Research Fund, and Deutsches Krebsforschungszentrum, A4.2. 

Lei ter, Joseph, Scheiderman, Marvin, Miller, Eugene, Data Processing Program of the Cancer Chemotherapy National Service Center, Abstracts of Papers, 136th Meeting, ACS, September 1959, p. 5G. 

Mouridsen H, Harvey V, Semiglazov V, et al. Phase III trial of docetaxel 100 versus 75 versus 60 mg/m2 as second line chemotherapy in advanced breast cancer (Meeting abstract). San Antonio Breast Cancer Symposium 2002 A327. 

Abstract Chemotherapy has been a major approach to treat cancer. Both constituents of... 

Vokes EE, Leopold KA, Herndon JE, et al. CALGB Study 9431 Arandomized phase study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy and concomitant chemoradiotherapy for unresectable stage III non-small cell lung cancer. Lung Cancer 2000 29(Sl) 49(Abstract 158). 

TishlerRB, Posner MR, Colevas AD, etal. Phase I study of concurrent taxotere/radiation after induction chemotherapy inpatients with squamous cell cancer of the head and neck (abstract 1547). Pro Am Soc Clin Oncol 1999 18 400a. 

Fossella FV, Zinner RG, Komaki R, et al. Gemcitabine with concurrent chest radiation followed by consolidation chemotherapy with gemcitabine plus cisplatin A phase I trial for patients with stage III non-small cell lung cancer. Lung Cancer 2000 29(Suppl 1) 111 (abstract 368). 

Lad T, Wagner H, Piantadosi S. Randomized Phase II evaluation of preoperative chemotherapy alone and radiotherapy alone in stage Ilia non-small cell lung cancer. (Abstract) Proc Amer Soc Clin Oncol 1991 10 258. 

Burkes R, Shepard F, Ginsberg R, et al. Induction chemotherapy with MVP in patients with stage IIIA (N2) unresectable non-small cell lung cancer. The Toronto experience (abstract 1078). Proc Am Soc Clin Oncol 1994 13 327. 

Johnson BE, Salem C, Nesbit J, et al. Limited stage small-cell lung cancer (SCLC) treated with concurrent BID chest radiotherapy (RT) and etoposide, cisplatin (VP/PT) followed by chemotherapy (CT) selected by in vitro drug sensitivity testing (abstract 818). ProcAm Soc Clin Oncol 1991 10 240. 

Thomas E, Buzdar A, HortobagyiG, etal. Long-Term Follow Up of Stage III Breast Cancer-Combined Modality Treatment with Anthracycline Containing Chemotherapy (CT) The MD Anderson Experience (Meeting abstract). ProcAnnu Meet Am Soc Clin Oncol 1999 18 A284. 

Earle CC, Maroun A. Adjuvant chemotherapy after curative resection for gastric cancer Revisiting a meta-analysis of randomized trials (abstract). Proc Am Soc Clin Oncol 1998. 

Slamon D, Leyland-Jones B, Shak S, Paton V, Bajamonde A, Flemiong T, Eirmann W, Wolter J, Baselga J, Norton L. Addition of Herceptin (humanized anti-HER2 antibody) to first line chemotherapy for HER2 overexpressing metastatic breast cancer (HER2-I-/MBC) markedly increases anticancer activity a randomised, multinational, controlled phase III trial (Abstract 377). Proc Am Soc Clin Oncol 1998 17 98a. 

Mamounas EP, Bryant J, Lembersky BC, et al. PacUtaxel (T) following doxorubicin/cyclophosphamide (AC) as adjuvant chemotherapy for node-positive breast cancer results from NSABP B-28 (Meeting abstract). Proc Am Soc CUn Oncol 2003 A 12. 

Green MC, Buzdar AU, Smith T, et al. Weekly (wkly) pacUtaxel (P) followed by FAC as primary systemic chemotherapy (PSC) of operable breast cancer improves pathologic complete remission (pCR) rates when compared to every 3-week (Q 3 wk) P therapy (tx) followed by FAC—final results of a prospective phase III randomized trial (Meeting abstract). Proc Am Soc Clin Oncol 2002 A135. 

Laurentiis MD, Martignetti A, Isernia G, et al. Amenorrhea induced by adjuvant chemotherapy in breast cancer patients strongly correlates with a better survival a long follow-up study (Meeting abstract). Proc Am Soc Qin Oncol 1998 A519. 

Depierre A, Quoix E, Mercier M, et al. Maintenance chemotherapy in advanced non-small cell lung cancer (NSCLC) A randomized study of vinorelbine (V) versus observation (OB) in patients (pts) responding to induction therapy. Proc Am Soc Clin Oncol 2001 20 309a (Abstract). 

Patt YZ, Lin E, Leibman J, et al. Capecitabine plus irinotecan for chemotherapy nai ve patients with metastatic colorectal cancer. Proc Am Soc Clin Oncol 2003 22 281 (Abstract 1130). 

Vasey R. Preliminary results of the SCOTROC trial A phase III comparison of paclitaxel-carboplatin (PC) and docetaxel-carboplatin (DC) as first-line chemotherapy for stage IC-IV epithelial ovarian cancer (EOC). Proc Am Soc Clin Oncol 2001 20 202a (Abstract). 

B. Kreukels and S. Schagen, et al., Electrophysiological Correlates of Information Processing in Breast Cancer Patients Treated with Adjuvant Chemotherapy, Breast Cancer Research and Treatment 94, no. 1 (2005) 53-61. Abstract accessed online at http www.springerlink.com/content/k122168q55u20013. 

M. Inagaki, et al. Smaller Regional Volumes of Brain Gray and White Matter Demonstrated in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy, Cancer 109, no. 1 (2006) 146-156. Abstract accessed online at http www3.interscience.wiley. com/cgi-bin/abstract/113489209/ABSTRACT. 

Geh JI, Bond SJ, Bentzen SM, et al (2006) Systemic overview of preoperative (neoadjuvant) chemoradiotherapy in patients with oesophageal cancer evidence of a radiation and chemotherapy dose response. Radiother Oncol 78 236-244 Gerard J, Romestaing P, Bonnetain F, et al (2005) Preoperative chemoradiotherapy (CT-RT) improves local control in T3-4 rectal cancers results of the FFCD 9203 randomized trial (abstract). Int J Radial Oncol Biol Phys 63(suppl 1) S2-S3... 

---